Valuation Yixintang Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 26/10/2026			5-day change	1st Jan Change
13.10 ^CNY	+3.23%		-1.06%	+1.87%

09-16	Yixintang Pharmaceutical Group Co., Ltd. Announces Interim Cash Dividend for 2026 for A Shares, Payable on 24 September 2026	CI
08-27	Yixintang Pharmaceutical Group Co., Ltd. Proposes Interim Cash Dividend for 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,959	18,782	13,803	7,625	7,383	7,521	-	-
Change	-	-18.19%	-26.51%	-44.76%	-3.16%	1.87%	-	-
Enterprise Value (EV) ¹	21,903	16,608	11,574	5,707	6,451	6,282	6,097	5,730
Change	-	-24.17%	-30.31%	-50.69%	13.04%	-2.62%	-2.94%	-6.03%
P/E	24.7x	18.6x	25.2x	67.6x	28.1x	16.7x	14x	11.6x
PBR	3.49x	2.53x	1.78x	1.02x	1.03x	1.01x	0.97x	0.93x
PEG	-	2.14x	-0.6x	-0.9x	0x	0.2x	0.7x	0.6x
Capitalization / Revenue	1.57x	1.08x	0.79x	0.42x	0.43x	0.43x	0.4x	0.38x
EV / Revenue	1.5x	0.95x	0.67x	0.32x	0.37x	0.36x	0.33x	0.29x
EV / EBITDA	16.9x	11x	10.6x	3.13x	9x	3.35x	2.9x	2.38x
EV / EBIT	20.5x	13.4x	11.8x	20.5x	15.3x	8.59x	7.22x	5.74x
EV / FCF	-	-	6.14x	3.89x	4.76x	5.71x	4.04x	3.04x
FCF Yield	-	-	16.3%	25.7%	21%	17.5%	24.8%	32.8%
Dividend per Share ²	0.3	0.4	0.4	0.3	0.2	0.3607	0.4926	0.6117
Rate of return	0.78%	1.27%	1.73%	2.3%	1.56%	2.75%	3.76%	4.67%
EPS ²	1.561	1.697	0.9206	0.1927	0.4571	0.7851	0.9351	1.13
Distribution rate	19.2%	23.6%	43.4%	156%	43.8%	45.9%	52.7%	54.1%
Net sales ¹	14,585	17,432	17,380	18,000	17,336	17,571	18,586	19,934
EBITDA ¹	1,295	1,511	1,087	1,823	716.6	1,874	2,101	2,411
EBIT ¹	1,066	1,243	982.9	278	422.4	731.7	844	997.9
Net income ¹	921.5	1,010	549.4	114.1	263.4	456.2	546.7	663.5
Net Debt ¹	-1,056	-2,174	-2,229	-1,917	-932	-1,239	-1,424	-1,791
Reference price ²	38.51	31.51	23.16	13.02	12.86	13.10	13.10	13.10
Nbr of stocks (in thousands)	596,181	596,071	596,005	585,604	574,128	574,128	-	-
Announcement Date	14/03/22	17/03/23	19/03/24	27/04/25	28/04/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.	16.16x	0.34x	3.23x	2.84%	1.09B
JD HEALTH INTERNATIONAL INC.	17.04x	0.7x	10.38x	-.--%	15.29B
RAIA DROGASIL S.A.	23.58x	0.98x	10.61x	1.91%	7.04B
MATSUKIYOCOCOKARA & CO.	17.07x	0.76x	7.93x	2.19%	6.58B
TSURUHA HOLDINGS INC.	21.05x	0.36x	5.64x	2.17%	6.44B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	19.76x	0.72x	12.44x	1.1%	5.91B
YIFENG PHARMACY CHAIN CO., LTD.	16.3x	1.02x	7.13x	2.59%	4.61B
COSMOS PHARMACEUTICAL CORPORATION	15.66x	0.46x	7.59x	1.34%	3.21B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	13.93x	0.59x	4.53x	5.19%	3.1B
CLICKS GROUP LIMITED	14.97x	0.89x	6.68x	4.33%	3.02B
Average	17.55x	0.68x	7.61x	2.37%	5.63B
Weighted average by Cap.	18.17x	0.71x	8.71x	1.72%